%PDF-1.4
%
54 0 obj
<>
endobj
51 0 obj
<>
endobj
119 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-05-11T18:09:38Z
2024-03-29T07:12:43-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T07:12:43-07:00
application/pdf
Heather
2003-472.june
uuid:3314a8d0-1dd2-11b2-0a00-ab0927fd5800
uuid:3314a8d3-1dd2-11b2-0a00-6a0000000000
endstream
endobj
40 0 obj
<>
endobj
41 0 obj
<>
endobj
55 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 24 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 26 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 28 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 30 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
141 0 obj
[145 0 R]
endobj
142 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6303 0.7762 -0.7762 0.6303 16.7778 46.0632 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.0811 Tw 10 0 0 10 54 713.1616 Tm
(predict outcome in patients with chronic pain, and to what)Tj
0.02499 Tw 0 -1.2 TD
(extent this is influenced by treatment.)Tj
/T1_2 1 Tf
0 Tw 0 -2.4 TD
(ACKNOWLEDGMENT)Tj
/T1_1 1 Tf
0.1647 Tw 8 0 0 8 54 667.1616 Tm
[(W)79.9 (e would like to thank )17.7 (T)35 (racey Crissell for setting up the database and)]TJ
0.02499 Tw 0 -1.25 TD
(Innica Halsey for her help with data input.)Tj
/T1_2 1 Tf
0 Tw 10 0 0 10 54 633.1616 Tm
(REFERENCES)Tj
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 61 623.1616 Tm
[(1.)-875.1 (Ber)17.7 (gman S, Herrstrom P)110.7 (, Jacobsen L)91.7 (TH, Petersson IF)79.7 (. Chronic)]TJ
1.675 -1.25 Td
(widespread pain: a three year follow-up of pain distribution and)Tj
T*
(risk factors. J Rheumatol 2002;29:518-25.)Tj
-1.675 -1.25 Td
[(2.)-875.1 (MacFarlane GJ, )17.7 (Thomas E, Papageor)17.7 (giou )54.8 (AC, Schollum J, Croft)]TJ
1.675 -1.25 Td
[(PR, Silman )54.8 (AJ. )17.7 (The natural history of chronic pain in the )]TJ
T*
(community: a better prognosis than in the clinic. J Rheumatol)Tj
0 Tc 0 Tw T*
(1996;23:1617-20.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(3.)-875.1 (Papageor)17.7 (giou )54.8 (AC, Silman )54.8 (AJ, MacFarlane GJ. Chronic widespread)]TJ
1.675 -1.25 Td
[(pain in the population: a seven year follow-up study)64.8 (. )54.8 (Ann Rheum)]TJ
0 Tc T*
(Dis 2002;61:1071-4.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(4.)-875.1 (Buskila D, )54.8 (Abramov G, Bijon )54.8 (A, Neumann L. )17.7 (The prevalence of)]TJ
1.675 -1.25 Td
(pain complaints in a general population in Israel and its )Tj
T*
(implications for utilization of health services. J Rheumatol )Tj
0 Tc 0 Tw T*
(1999;27:1521-5.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(5.)-875.1 (Andersson HI, Ejlertsson G, Leden I, Rosenber)17.7 (g C. Characteristics)]TJ
1.675 -1.25 Td
(of subjects with chronic pain in relation to local and widespread)Tj
T*
(pain report. Scand J Rheumatol 1996;25:146-54.)Tj
-1.675 -1.25 Td
[(6.)-875.1 (T)69.9 (opic )17.7 (W)79.9 (orking Group. NHS Research and development strategic)]TJ
1.675 -1.25 Td
[(review)64.8 (. NHS; 1999. [Internet]. )54.8 (Accessed February 1)36.8 (1, 2004.)]TJ
T*
[(A)74 (vailable from: http://www)64.8 (.doh.gov)64.9 (.)]TJ
0 Tw T*
(uk/research/documents/rd3/primary_care_final_report.pdf )Tj
0.02499 Tw -1.675 -1.25 Td
[(7.)-875.1 (McBeth J, MacFarlane GJ, Hunt IM, Silman )54.8 (AJ. Risk factors for)]TJ
1.675 -1.25 Td
[(persistent chronic widespread pain: a community based study)64.8 (.)]TJ
T*
(Rheumatology 2001;40:95-101.)Tj
-1.675 -1.25 Td
[(8.)-875.1 (McBeth J, MacFarlane GJ, Benjamin S, Silman )54.8 (AJ. Features of)]TJ
1.675 -1.25 Td
[(somatisation predict the onset of chronic widespread pain. )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 2001;44:940-6.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(9.)-875.1 (Ledingham J. Doherty S, Doherty M. Primary fibromyalgia)]TJ
1.675 -1.25 Td
[(syndrome: an outcome study)64.8 (. Br J Rheumatol 1993;32:139-42.)]TJ
-2.175 -1.25 Td
[(10.)-875.1 (Bandura )54.8 (A. Self-ef)17.7 (ficacy: toward a unifying theory of behavioural)]TJ
0 Tc 2.175 -1.25 Td
(change. Psychol Rev 1977;84:191-215.)Tj
-0.00011 Tc 30.8619 48.921 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Nicholas MK. Self-ef)17.7 (ficacy and chronic pain. Paper presented at the)]TJ
2.1381 -1.25 Td
(annual conference of the British Psychological Society 1989.)Tj
-2.175 -1.25 Td
[(12.)-875.1 (Asghari )54.8 (A, Nicholas MK. Pain self-ef)17.7 (ficacy beliefs and pain )]TJ
2.175 -1.25 Td
[(behaviour)54.8 (. )54.8 (A)-220.1 (prospective study)64.9 (. Pain 2001;94:85-100.)]TJ
-2.175 -1.25 Td
[(13.)-875.1 (Arnstein P)110.7 (, Caudill M, Mandle CL, Norris )54.8 (A, Beasley R. Self )]TJ
2.175 -1.25 Td
[(ef)17.7 (ficacy as a mediator of the relationship between pain intensity)64.8 (,)]TJ
T*
(disability and depression in chronic pain patients. Pain)Tj
0 Tc 0 Tw T*
(1999;80:483-91.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(14.)-875.1 (Strong J, )17.7 (W)79.9 (estbury K, Smith G, McKenzie I, R)39.7 (yan )17.7 (W)91.8 (.)-0.1 ( )17.7 (T)35 (reatment)]TJ
2.175 -1.25 Td
(outcome in individuals with chronic pain: is the Pain Stages of)Tj
T*
(Change Questionnaire \(PSOCQ\) a useful tool? Pain 2002;97:65-73. )Tj
-2.175 -1.25 Td
[(15.)-875.1 (Buskila D, Neumann L, Odes LR, Schleifer E, Depsames R, )]TJ
2.175 -1.25 Td
[(Abu-Shakra M. )17.7 (The prevalence of musculoskeletal pain and)]TJ
T*
(fibromyalgia in patients hospitalised on internal medicine wards.)Tj
T*
[(Semin )54.8 (Arthritis Rheum 2001;30:41)36.8 (1-7.)]TJ
-2.175 -1.25 Td
[(16.)-875.1 (Leveille SG, Ling S, Hochber)17.7 (g MC, Resnick HE, Bandeen-Roche)]TJ
2.175 -1.25 Td
[(KJ, )17.7 (W)79.9 (on )54.8 (A, Guralnik JM. )17.7 (W)39.9 (idespread musculoskeletal pain and the)]TJ
T*
[(progression of disability in older disabled women. )54.8 (Ann Intern Med)]TJ
0 Tc 0 Tw T*
(2001;135:1038-46.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(17.)-875.1 (W)39.8 (i)0.1 (lliams )54.8 (AC, Richardson PH, Nicholas MK, et al. Inpatient vs)]TJ
2.175 -1.25 Td
(outpatient pain management: results of a randomised controlled)Tj
T*
(trial. Pain 1996;66:13-22.)Tj
-2.175 -1.25 Td
[(18.)-875.1 (Farraz MB, Quaresma MR, )54.8 (Aquino LR, )54.8 (Atra E, )17.7 (T)35 (ugwell P)110.8 (,)]TJ
2.175 -1.25 Td
(Goldsmith CH. Reliability of pain scales in the assessment of)Tj
T*
(literate and illiterate patients with rheumatoid arthritis. J Rheumatol)Tj
0 Tc 0 Tw T*
(1990;17:1022-4.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(19.)-875.1 (W)79.9 (olfe F)79.7 (, Smythe HA, )36.8 (Y)110.8 (unus MB, et al. )17.7 (The )54.8 (American College of)]TJ
2.175 -1.25 Td
(Rheumatology 1990 criteria for the classification of fibromyalgia.)Tj
T*
(Arthritis Rheum 1990;33:160-72.)Tj
-2.175 -1.25 Td
[(20.)-875.1 (MacFarlane GJ, Morris S, Hunt IM, et al. Chronic widespread pain)]TJ
2.175 -1.25 Td
(in the community: the influence of psychological symptoms and)Tj
T*
[(mental disorder on healthcare seeking behaviour)54.8 (. J Rheumatol)]TJ
0 Tc 0 Tw T*
(1999;26:413-9. )Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(21.)-875.1 (White KP)110.7 (, Nielson )17.7 (WR, Harth M, Ostbye )17.7 (T)74 (, Speechley M. Chronic)]TJ
2.175 -1.25 Td
(widespread musculoskeletal pain with or without fibromyalgia:)Tj
T*
(psychological distress in a representative community adult sample.)Tj
T*
(J Rheumatol 2002;29:588-94.)Tj
-2.175 -1.25 Td
[(22.)-875.1 (Rhodes LA, McPhillips-T)69.7 (angum CA, Markham C, Klenk R. )17.7 (The)]TJ
2.175 -1.25 Td
(power of the visible: the meaning of dogmatic tests in chronic back)Tj
T*
[(pain. Soc Sci Med 1999;48:1)36.8 (189-203.)]TJ
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_3 1 Tf
8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2004; 31:6)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(1192)Tj
ET
0 0 0 0 k
/GS0 gs
109.25 59.09 396.47 -10.83 re
f*
0.5 w
109.25 59.09 396.47 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_4 8 Tf
119.868 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_5 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
34 0 obj
<>stream
8;Z\6>Ah>4%+G/.W9XkmbstYl8R5iA!:-C^4BW2P@Zn9=gV:%mXe.NW4LE/\/R5uI
kWN4fDr
>C9oQJGQu"?VF.P#+-RDPKs7L5jfOCen(Y#8)0;-,U6C0=U<60]oiNo,m4o6P)T6;
/CHl$&cFP;&C(TP#\Kl;9)*Pcj1I7"5i>hF.^pC(#=9EAf43@(Y6['M%'GHRY?qJr
,h8ZG$M^Ye=GtOWKmG3VpW,_ITN^kdq.#Vc@L`,;WU`[CZmerB)HU:&]'HA<`+Cfe
*CQi?q4+IP)%[9JgT.&V&=!P5Pi9FX!LMIX/"56XDe_OKY2jGS_]!.XK9D@51m7+'
8,V6NM$(<(;*$VIr)t/])K*s5C@j?HoNDMaii:skfNLf7jm\g[TjK"W2(RS@]FSsP
eL.c&7n2D[.2KR0I*[o@fR`#R5c+@=D5?T>;5L9fs10bcdCsY
endstream
endobj
38 0 obj
[/Indexed/DeviceRGB 255 37 0 R]
endobj
37 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
106 0 obj
<>
endobj
64 0 obj
<>
endobj
16 0 obj
<>
endobj
57 0 obj
<>
endobj
93 0 obj
<>
endobj
124 0 obj
<>
endobj
58 0 obj
<>
endobj
85 0 obj
<>stream
HUkPgǗ|" ˮHiASoXDDKK$BpI BH$ @r)X@@ezGku]f/ݨsfy/05a`fut`C0!wu~' ]1z Mb-MY-MiwK
Eu`x,8mZ]]2#;Μ)%9ki_ّOrBnqNr8ii7N6W5fL 8 avB7=!E\Ύ@NBFF~6g$
xIlWk[o%ae°`d36c'a3>0.36F(#sr0dI-n6g2x\a&ISZe{~e&o춙حٳC)RR7b^,ߺw/eO"M9lc%~RN\~R9xz.@**%guAPA*%Z "ĠYL6d{?.+G%zk{_pJŤmQ>@Yȳeɀ1TZ}8zMc@/zdԼdϑ#rxWꟵKɮ@8lH)[~.QȪk4.4RUqDdaPѲ*z'S1~=3CJ:_x8y"ȤV\.Wu5m|~:(q iѧbYl\C(OqZG:*r9ҐCi$ł|E_ x]td[+<_"ȰRۄe2'aIMjm` 9Zދ9 -lh,k"gq